Influence of liver cancer on lipid and lipoprotein metabolism
Open Access
- 3 March 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 5 (1), 4
- https://doi.org/10.1186/1476-511x-5-4
Abstract
Liver plays a key role in the metabolism of plasma apolipoproteins, endogenous lipids and lipoproteins. Hepatocellular carcinoma (HCC) is one of the most common fatal malignant tumors in China and in other Southeast Asian countries. This has been attributed to the high incidence of hepatitis B infection. Hepatitis B proteins, such as the hepatitis B X protein (HBx) that is large hepatitis B surface protein could regulate transcription of many candidate genes for liver carcinogenesis. It has known that patients who suffered from acute hepatitis B could have lipid disorders such as decreased plasma level of high-density lipoproteins (HDL). Furthermore, aberrations of lipid metabolism are often seen in the chronic hepatitis B infection.Plasma lipid profiles could be changed under HCC. In majority of the reports in HCC, plasma levels of triglycerides (TG), cholesterol, free fatty acids (FFA), HDL, low-density lipoproteins (LDL), lipoprotein (a) (Lp(a)), apolipoprotein AI (apoAI) and apoB were slight to significantly decreased, however, in some cases plasma levels of TG and Lp(a) might be increased. It has been suggested that analysis of plasma levels of lipids, lipoproteins and apolipoproteins in the patients suffered from HCC reflects on the hepatic cellular impairment status. Studies revealed that alterations seen in the plasma levels of lipids, lipoproteins and apolipoproteins reflecting patients' pathologic conditions. Decreased serum levels of cholesterol and apoAI may indicate a poor prognosis.Human leukaemic cells and certain tumor tissues have a higher receptor-mediated uptake of HDL and LDL than the corresponding normal cells or tissues. LDL and HDL have therefore been proposed as a carrier for the water-insoluble anti-cancer agents.Keywords
This publication has 106 references indexed in Scilit:
- Total Cholesterol and Body Mass Index in Relation to 40-Year Cancer Mortality (The Corfu Cohort of the Seven Countries Study)Cancer Epidemiology, Biomarkers & Prevention, 2005
- New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol TransportCirculation Research, 2005
- Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of CancerPreventive Medicine, 1999
- Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase DeficienciesJournal of Clinical Endocrinology & Metabolism, 1997
- Estimation of dolichol and cholesterol synthesis in microsomes and peroxisomes isolated from rat liverFEBS Letters, 1995
- Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a)The American Journal of Cardiology, 1990
- Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.JCI Insight, 1989
- Serum Apolipoproteins A-I, A-II and B in Hepatic Metastases Comparison with other Liver Diseases: Hepatomas and Cirrhosiscclm, 1986
- Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.JCI Insight, 1983
- Serum Lipids in HepatomaOncology, 1979